Abacus Planning Group’s Acadia Healthcare ACHC Stock Holding History

Abacus Planning Group’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,000	Closed	-$409K	–	149
2018 Q2	$409K	Buy	+10,000	New	+$403K	0.31%	78

Other funds holding ACHC

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Abacus Planning Group's ACHC Position: Q3 2018 in Review

Abacus Planning Group sold out of Acadia Healthcare (ACHC) in Q3 2018, closing a stake of 10,000 shares — an estimated $409K sold.

Abacus Planning Group first reported a position in ACHC in Q2 2018 and held it in 1 quarter. The position peaked at $409K in Q2 2018. 253 funds tracked by Wall St. Rank hold ACHC as of Q3 2018.

Abacus Planning Group reported no remaining Acadia Healthcare position as of Q3 2018 after selling out during the quarter.
Abacus Planning Group sold 10,000 Acadia Healthcare shares in Q3 2018, an estimated $409K.
Abacus Planning Group first reported a position in Acadia Healthcare in Q2 2018 and held it in 1 quarter.
Abacus Planning Group's Acadia Healthcare position peaked at $409K in Q2 2018.
253 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2018.

Based on Abacus Planning Group's 13F filing for Q3 2018, filed 31 Oct 2018.